NPS RADAR February 2004NPS RADAR February 2004

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
NPS RADAR February 2004 Professional publication - NPS RADAR - Complete issue NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Deferiprone (Ferriprox) for thalassaemia major Professional publication - NPS RADAR - Review Reviews use of deferiprone for thalassaemia major in patients unable to take desferrioxamine and notes Section 100 Private hospital authority requirement.
Escitalopram (Lexapro) for major depressive disorder Professional publication - NPS RADAR - Review Reviews use of escitalopram for major depressive disorder, including comparison with citalopram and isomer drug design.
Medicines used in palliative care Professional publication - NPS RADAR - Review Describes Palliative Care Section of the Schedule of Pharmaceutical Benefits and lists medicines included in this section.
Triptans for migraine Professional publication - NPS RADAR - Review PBAC has increased maximum quantity of naratriptan, sumatriptan, and zolmitriptan to 4 tablets with 5 repeats for patients with more than one migraine each month.

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Date published: 2004-02-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.